Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
36
Number of overlapping holdings
87.8%
% of XPH's 41 holdings also in IHE
97.3%
% of IHE's 38 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ZOETIS INC | 3.7% | 4.6% | 3.7% |
|
JOHNSON & JOHNSON | 3.7% | 22.8% | 3.7% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% | 4.6% | 3.7% |
|
BRISTOL-MYERS SQUIBB CO | 3.7% | 4.6% | 3.7% |
|
ELI LILLY & CO | 3.7% | 22.7% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to IHE
|
TARSUS PHARMACEUTICALS, INC. | 3.1% |
|
EDGEWISE THERAPEUTICS, INC. | 2.7% |
|
PACIRA PHARMACEUTICALS INC | 2.4% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 2.3% |
 |
PERRIGO CO | 2.2% |
|
AMPHASTAR PHARMACEUTICALS INC | 2.2% |
|
ORGANON & CO. | 2.0% |
|
ARVINAS, INC. | 2.0% |
|
PRESTIGE BRANDS HOLDINGS INC | 1.8% |
|
AXSOME THERAPEUTICS, INC. | 1.7% |
XPH Underweight Relative to IHE
|
JOHNSON & JOHNSON | -19.1% |
|
ELI LILLY & CO | -19.0% |
|
ZOETIS INC | -0.8% |
|
INTRA-CELLULAR THERAPIES INC | -0.8% |
|
BRISTOL-MYERS SQUIBB CO | -0.8% |
|
PFIZER INC | -0.8% |
|
MERCK & CO. INC. | -0.8% |
|
ROYALTY PHARMA PLC CLASS A | -0.8% |
|
VIATRIS, INC. | -0.8% |
 |
THERAVANCE BIOPHARMA INC | -0.1% |